Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction AdenocarcinomaThe article discusses the development of a virtual pharmacy for inmates, enhancing access and efficiency in healthcare services within correctional facilities.